Li C - Search Results

1

The Diagnostic Value of ¹⁸F-FDG PET/CT Bone Marrow Uptake Pattern in Detecting Bone Marrow Involvement in Pediatric Neuroblastoma Patients.

Liu J, Li C, Yang X, Lu X, Zhang M, Qian L, Wang W, Kan Y, Yang J. Liu J, et al. Among authors: li c. Contrast Media Mol Imaging. 2022 Jan 6;2022:7556315. doi: 10.1155/2022/7556315. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 35082556 Free PMC article.

2

⁶⁴Cu-labeled daratumumab F(ab')₂ fragment enables early visualization of CD38-positive lymphoma.

Kang L, Li C, Yang Q, Sutherlin L, Wang L, Chen Z, Becker KV, Huo N, Qiu Y, Engle JW, Wang R, He C, Jiang D, Xu X, Cai W. Kang L, et al. Among authors: li c. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1470-1481. doi: 10.1007/s00259-021-05593-9. Epub 2021 Oct 22. Eur J Nucl Med Mol Imaging. 2022. PMID: 34677626 Free PMC article.

3

FDG PET/CT Demonstrated Epstein-Barr Virus-Associated Leiomyosarcoma in a Pediatric Patient With Wiskott-Aldrich Syndrome.

Li C, Yang X, Lu X, Wang W, Yang J. Li C, et al. Clin Nucl Med. 2022 Feb 1;47(2):190-191. doi: 10.1097/RLU.0000000000004020. Clin Nucl Med. 2022. PMID: 35006111

4

Noninvasive Evaluation of Multidrug Resistance via Imaging of ABCG2/BCRP Multidrug Transporter in Lung Cancer Xenograft Models.

Li C, Yang Q, Chen Z, Qiu Y, Du Y, Wang R, He Q, Yang J, Zhen H, Kang L. Li C, et al. Mol Pharm. 2022 Oct 3;19(10):3521-3529. doi: 10.1021/acs.molpharmaceut.1c00939. Epub 2022 Apr 15. Mol Pharm. 2022. PMID: 35427142

5

The prognostic value of ¹⁸F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients.

Liu J, Si Y, Zhou Z, Yang X, Li C, Qian L, Feng LJ, Zhang M, Zhang SX, Liu J, Kan Y, Gong J, Yang J. Liu J, et al. Among authors: li c. Cancer Imaging. 2022 Jul 5;22(1):32. doi: 10.1186/s40644-022-00472-4. Cancer Imaging. 2022. PMID: 35791003 Free PMC article.

6

Theranostic application of ⁶⁴Cu/¹⁷⁷Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models.

Li C, Liu J, Yang X, Yang Q, Huang W, Zhang M, Zhou D, Wang R, Gong J, Miao Q, Kang L, Yang J. Li C, et al. Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):168-183. doi: 10.1007/s00259-022-05954-y. Epub 2022 Sep 5. Eur J Nucl Med Mol Imaging. 2022. PMID: 36063202

7

ImmunoPET of CD146 in Orthotopic and Metastatic Breast Cancer Models.

Li C, Kang L, Fan K, Ferreira CA, Becker KV, Huo N, Liu H, Yang Y, Engle JW, Wang R, Xu X, Jiang D, Cai W. Li C, et al. Bioconjug Chem. 2021 Jul 21;32(7):1306-1314. doi: 10.1021/acs.bioconjchem.0c00649. Epub 2021 Jan 21. Bioconjug Chem. 2021. PMID: 33475350 Free PMC article.

8

Theranostic role of ⁸⁹Zr- and ¹⁷⁷Lu-labeled aflibercept in breast cancer.

Yang Q, Chen Z, Qiu Y, Huang W, Wang T, Song L, Sun X, Li C, Xu X, Kang L. Yang Q, et al. Among authors: li c. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1246-1260. doi: 10.1007/s00259-023-06575-9. Epub 2023 Dec 23. Eur J Nucl Med Mol Imaging. 2024. PMID: 38135849

9

Correction to: Theranostic role of ⁸⁹Zr‑ and ¹⁷⁷Lu‑labeled aflibercept in breast cancer.

Yang Q, Chen Z, Qiu Y, Huang W, Wang T, Song L, Sun X, Li C, Xu X, Kang L. Yang Q, et al. Among authors: li c. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1495. doi: 10.1007/s00259-023-06590-w. Eur J Nucl Med Mol Imaging. 2024. PMID: 38212532 No abstract available.

10

CD38-Targeted Theranostics of Lymphoma with ⁸⁹Zr/¹⁷⁷Lu-Labeled Daratumumab.

Kang L, Li C, Rosenkrans ZT, Huo N, Chen Z, Ehlerding EB, Huo Y, Ferreira CA, Barnhart TE, Engle JW, Wang R, Jiang D, Xu X, Cai W. Kang L, et al. Among authors: li c. Adv Sci (Weinh). 2021 Mar 15;8(10):2001879. doi: 10.1002/advs.202001879. eCollection 2021 May. Adv Sci (Weinh). 2021. PMID: 34026426 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83,004 results

Search Page